BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37195732)

  • 1. Benralizumab: A novel treatment for the cutaneous features of paediatric eosinophilic granulomatosis with polyangiitis (pEGPA).
    Bandla M; Howard M; McNally A; Armstrong D; Simpson I; Mar A
    Australas J Dermatol; 2023 Aug; 64(3):404-407. PubMed ID: 37195732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis.
    Belfeki N; Abroug S; Ghriss N; Chouchane I; Hamrouni S; Strazzulla A; Zayet S
    Clin Exp Rheumatol; 2021 Oct; 40(4):834-837. PubMed ID: 35522541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benralizumab in eosinophilic granulomatosis with polyangiitis complicated by Staphylococcus aureus sepsis.
    Kolios AGA; Lutterotti A; Kulcsar Z; Renner T; Rudiger A; Nilsson J
    Clin Immunol; 2021 Jan; 222():108574. PubMed ID: 32805452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].
    Carrette A; Mercier V; Lelubre C; Peché R
    Rev Mal Respir; 2022 Sep; 39(7):621-625. PubMed ID: 35909008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset of eosinophilic granulomatosis with polyangiitis without eosinophilia and eosinophilic infiltration under benralizumab treatment: A case report.
    Yonezawa H; Ohmura SI; Ohkubo Y; Otsuki Y; Miyamoto T
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):145-149. PubMed ID: 37243733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis.
    Guntur VP; Manka LA; Denson JL; Dunn RM; Dollin YT; Gill M; Kolakowski C; Strand MJ; Wechsler ME
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1186-1193.e1. PubMed ID: 33065367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SUCCESSFUL TREATMENT FOR OTITIS MEDIA AND SINUSITIS ASSOCIATED WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS USING ANTI-IL-5 RECEPTOR MONOCLONAL ANTIBODY BENRALIZUMAB].
    Sugiyama T; Yoshida S; Kikuchi S; Iino Y
    Arerugi; 2022; 71(3):242-247. PubMed ID: 35569946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab.
    Chica-Guzmán MV; Morillo-Guerrero R; Carrón-Herrero A; González-de-Olano D; Almonacid-Sánchez C
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):228-230. PubMed ID: 32407950
    [No Abstract]   [Full Text] [Related]  

  • 9. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
    Bettiol A; Urban ML; Padoan R; Groh M; Lopalco G; Egan A; Cottin V; Fraticelli P; Crimi C; Del Giacco S; Losappio L; Moi L; Cinetto F; Caminati M; Novikov P; Berti A; Cameli P; Cathébras P; Coppola A; Durel CA; Folci M; Lo Gullo A; Lombardi C; Monti S; Parronchi P; Rivera CM; Solans R; Vacca A; Espígol-Frigolé G; Guarnieri G; Bianchi FC; Marchi MR; Tcherakian C; Kahn JE; Iannone F; Venerito V; Desaintjean C; Moroncini G; Nolasco S; Costanzo GAML; Schroeder JW; Ribi C; Tesi M; Gelain E; Mattioli I; Bello F; Jayne D; Prisco D; Vaglio A; Emmi G;
    Lancet Rheumatol; 2023 Dec; 5(12):e707-e715. PubMed ID: 38251561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
    BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Safety and Efficacy of Benralizumab for Eosinophilic Granulomatosis with Polyangiitis Complicated with Severe Neuropathy.
    Koga Y; Yoshimi S; Harada T; Suzuki S; Ohtsuka T; Dobashi K; Hisada T
    Intern Med; 2023 May; 62(10):1553-1556. PubMed ID: 36171130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
    Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis.
    Lee Y; Hojjati M
    J Clin Rheumatol; 2021 Dec; 27(8S):S401-S402. PubMed ID: 32453217
    [No Abstract]   [Full Text] [Related]  

  • 14. Benralizumab in eosinophilic granulomatosis with polyangiitis.
    Laorden D; Romero D; Domínguez-Ortega J
    Med Clin (Barc); 2022 May; 158(9):441-442. PubMed ID: 34728088
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
    Bettiol A; Urban ML; Bello F; Fiori D; Mattioli I; Lopalco G; Iannone F; Egan A; Dagna L; Caminati M; Negrini S; Bargagli E; Folci M; Franceschini F; Padoan R; Flossmann O; Solans R; Schroeder J; André M; Moi L; Parronchi P; Roccatello D; Sciascia S; Jayne D; Prisco D; Vaglio A; Emmi G;
    Ann Rheum Dis; 2022 Dec; 81(12):1769-1772. PubMed ID: 35850947
    [No Abstract]   [Full Text] [Related]  

  • 16. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    Wechsler ME; Nair P; Terrier B; Walz B; Bourdin A; Jayne DRW; Jackson DJ; Roufosse F; Börjesson Sjö L; Fan Y; Jison M; McCrae C; Necander S; Shavit A; Walton C; Merkel PA;
    N Engl J Med; 2024 Mar; 390(10):911-921. PubMed ID: 38393328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
    Frątczak A; Polak K; Miziołek B; Bergler-Czop B
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. Reply.
    Wechsler ME; Fan Y; Merkel PA
    N Engl J Med; 2024 May; 390(20):1940. PubMed ID: 38810204
    [No Abstract]   [Full Text] [Related]  

  • 19. Mepolizumab: Therapeutic strategy for a pediatric patient with eosinophilic granulomatosis with polyangiitis.
    Ozola L; Aleksejeva E; Stoldere D; Dāvidsone Z; Šantere R; Grantiņa I; Cīrule I; Krams A
    Pediatr Pulmonol; 2023 Mar; 58(3):973-979. PubMed ID: 36404638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother.
    Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N
    Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.